Guardian Pharmacy Services, Inc. (GRDN) Shareholder Equity
- 2026-06-30: Additional Paid in CapitalUSD $144.04M; Retained Earnings (Accumulated Deficit)USD $101.51M; Stockholders' Equity, Including Portion Attributable to Noncontrolling InterestUSD $257.64M; Noncontrolling Interest in Net Income (Loss) Other Noncontrolling Interests, RedeemableUSD (m).
- 2026-03-31: Additional Paid in CapitalUSD $141.19M; Retained Earnings (Accumulated Deficit)USD $79.64M; Stockholders' Equity, Including Portion Attributable to Noncontrolling InterestUSD $232.42M; Noncontrolling Interest in Net Income (Loss) Other Noncontrolling Interests, RedeemableUSD (m).
- 2025-12-31: Additional Paid in CapitalUSD $139.35M; Retained Earnings (Accumulated Deficit)USD $66.34M; Stockholders' Equity, Including Portion Attributable to Noncontrolling InterestUSD $217.92M; Noncontrolling Interest in Net Income (Loss) Other Noncontrolling Interests, RedeemableUSD (m).
- 2025-09-30: Additional Paid in CapitalUSD $138.27M; Retained Earnings (Accumulated Deficit)USD $45.42M; Stockholders' Equity, Including Portion Attributable to Noncontrolling InterestUSD $195.50M; Noncontrolling Interest in Net Income (Loss) Other Noncontrolling Interests, RedeemableUSD (m).
Guardian Pharmacy Services, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Additional Paid in Capital USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD | Noncontrolling Interest in Net Income (Loss) Other Noncontrolling Interests, Redeemable USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Partners' Capital Account, Contributions USD |
|---|---|---|---|---|---|---|
| 2026-06-30 | $144.04M | $101.51M | $257.64M | (m) | 3 month · $2.90M | 3 month · $574.00K |
| 2026-03-31 | $141.19M | $79.64M | $232.42M | (m) | 3 month · $1.79M | 3 month · $79.00K |
| 2025-12-31 | $139.35M | $66.34M | $217.92M | (m) | 12 month · $13.87M | 12 month · $1.97M |
| 2025-09-30 | $138.27M | $45.42M | $195.50M | (m) | 3 month · $4.37M | 3 month · $390.00K |
| 2025-06-30 | $133.90M | $35.60M | $179.67M | (m) | 3 month · $4.45M | 3 month · $1.09M |
| 2025-03-31 | $129.45M | $26.57M | $163.22M | (m) | 3 month · $3.97M | 3 month · $135.00K |
| 2024-12-31 | $125.48M | $17.12M | $149.98M | 12 month · $-96.00K | 12 month · $3.57M | (m) |
| 2024-09-30 | $122.32M | $5.18M | $133.90M | 3 month · $6.00K | (m) | (m) |
| 2024-06-30 | (m) | (m) | $57.21M | (m) | (m) | 3 month · $724.00K |
| 2024-03-31 | (m) | (m) | $56.57M | (m) | (m) | 3 month · $428.00K |
| 2023-12-31 | (m) | (m) | $59.86M | (m) | (m) | (m) |
| 2023-09-30 | (m) | (m) | $59.70M | (m) | (m) | 3 month · $223.00K |
| 2023-06-30 | (m) | (m) | $76.78M | (m) | (m) | 3 month · $120.00K |
| 2023-03-31 | (m) | (m) | $72.72M | (m) | (m) | 3 month · $195.00K |
| 2022-12-31 | (m) | (m) | $75.93M | (m) | (m) | (m) |